RGD-DOTA Example Archive

Preliminary Therapy Evaluation of 225Ac-DOTA-c (RGDyK) Demonstrates that Cerenkov Radiation Derived from 225Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization.
Pandya, Darpan N., et al. Theranostics 6.5 (2016): 698.
DOTA-c(RGDyK) was purchased from CPC Scientific, Inc. (Sunnyvale, CA), and its purity and mass were confirmed at Wake Forest using HPLC and electrospray ionization (ESI) mass spectrometry as described below.

Published On: March 2nd, 2016Categories: Citations, Metal Chelates, Peptide Macrocycles, Showcase Peptide Chelates
Learn More

The CPC Scientific website uses cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our Privacy Policy. Accept Reject

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

RGD-DOTA Example Archive

Preliminary Therapy Evaluation of 225Ac-DOTA-c (RGDyK) Demonstrates that Cerenkov Radiation Derived from 225Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization.

Title